What are Caterpillar's total assets?

Caterpillar (CAT) holds $95.6B in total assets, up 12.4% year over year.

How much cash does Caterpillar have?

Caterpillar holds $4.1B in cash and equivalents.

Can Caterpillar cover its short-term obligations?

Its current ratio is 1.35 — current assets exceed current liabilities.

Where does Caterpillar's balance sheet data come from?

Every line is extracted from Caterpillar's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Caterpillar CAT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$4.07B+14.3%	$9.99B+44.8%	$7.54B+33.7%	$5.44B+25.4%	$3.56B-28.2%
Accounts receivable, net	$11.45B+25.6%	$10.92B+17.6%	$10.15B+11.7%	$9.7B+3.0%	$9.12B-1.9%
Prepaid expenses and other current assets	$2.98B+5.5%	$2.8B-10.2%	$2.86B-7.5%	$2.87B+4.8%	$2.82B-6.2%
Trading assets	——	$748M-41.1%	——	——	——
Derivative assets	——	$336M+21.7%	——	——	——
Raw materials	——	$7.43B+11.3%	——	——	——
Work in process	——	$1.6B+11.1%	——	——	——
Finished goods	——	$8.73B+4.8%	——	——	——
Total current assets	$48.57B+12.9%	$52.49B+14.9%	$49.82B+10.8%	$46.76B+8.5%	$43.02B-1.5%
Property and equipment, net	$15.25B+13.5%	$15.14B+13.3%	$14.31B+11.5%	$13.9B+10.4%	$13.43B+7.1%
Accumulated depreciation	——	$16.77B+4.0%	——	——	——
Operating lease right-of-use assets	——	4%+1.0%	——	——	——
Goodwill	$5.87B+11.3%	$5.32B+1.5%	$5.33B+0.2%	$5.33B+1.3%	$5.27B-0.1%
Available-for-sale securities	——	$1.5B-16.2%	——	——	——
Total assets	$95.55B+12.4%	$98.59B+12.3%	$93.72B+8.6%	$90.33B+8.4%	$84.97B+1.5%
Deferred revenue	$4.38B+48.5%	$3.31B+42.7%	$3.39B+41.1%	$3.41B+46.8%	$2.95B+34.5%
Current portion of long-term debt	——	$5.51B+25.5%	——	——	——
Operating lease liabilities, current	——	$158M+10.5%	——	——	——
Contract liabilities	——	$4.68B+70.4%	——	——	——
Dividends payable	$0—	$703M+4.3%	$0—	$707M+3.4%	$0—
Derivative liabilities	——	$165M-57.1%	——	——	——
Total current liabilities	$35.9B+10.1%	$36.56B+13.3%	$35.99B+11.7%	$34.93B+4.1%	$32.6B+0.7%
Deferred tax liabilities	——	$1.37B+7.6%	——	——	——
Operating lease liabilities, non-current	——	$570M+24.2%	——	——	——
Other non-current liabilities	$6.69B+36.1%	$6.18B+26.3%	$5.67B+17.2%	$5.17B+7.5%	$4.92B+1.8%
Total liabilities	$76.89B+14.9%	$77.27B+13.2%	$73.06B+9.3%	$71.66B+8.3%	$66.9B+1.2%
Retained earnings	$68B+10.8%	$65.45B+10.3%	$64.46B+11.3%	$62.16B+12.1%	$61.36B+13.4%
Accumulated other comprehensive income (loss)	-$1.88B+14.7%	-$1.77B+28.3%	-$1.72B-0.3%	-$1.68B+24.5%	-$2.21B-5.4%
Total stockholders' equity	——	$21.32B+9.4%	——	——	——
Total liabilities and stockholders' equity	$95.55B+12.4%	$98.59B+12.3%	$93.72B+8.6%	$90.33B+8.4%	$84.97B+1.5%
Commitments and contingencies	——	——	——	——	——
Available-for-Sale Debt Securities - Amortized Cost	——	$744M-41.6%	——	——	——
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	——	$744M-41.6%	——	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	——	$763M-40.9%	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	——	$763M-40.9%	——	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	$177M-79.8%	——	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	——	$177M-79.8%	——	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position	——	$26M-67.9%	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	——	$763M-40.9%	——	——	——
AFS and Trading Securities - Unrealized Loss Position Fair Value	——	$940M-56.6%	——	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	$177M-79.8%	——	——	——
Allowance for Credit Losses - Receivable (Current)	——	$277M+5.7%	——	——	——
Cash, Cash Equivalents, and Marketable Securities	——	$940M-56.6%	——	——	——
Finished goods	——	$8.73B+4.8%	——	——	——
Inventory Supplies Net Of Reserves	——	$378M-0.3%	——	——	——
Derivative Assets - Fair Value	——	$496M+7.4%	——	——	——
Derivative Assets - Net Reduction from Master Netting Arrangements	——	$160M-14.0%	——	——	——
Equipment Installment Plan Receivables, Gross	——	$25.15B+9.2%	——	——	——
Finance Receivables (Current)	$10.44B+8.2%	$10.65B+11.3%	$10.32B+5.1%	$10.15B+6.6%	$9.66B+2.2%
Financing Receivables	——	$25.15B+9.2%	——	——	——
Percentage of Inventory on LIFO Basis	——	70%+5.0%	——	——	——
Inventory LIFO Reserve	——	$4.31B+11.4%	——	——	——
Operating Lease Income - 2022 (Lessor)	——	$896M+3.2%	——	——	——
Operating Lease Income - 2025 (Lessor)	——	$200M+13.6%	——	——	——
Accumulated Goodwill Impairment Losses	——	$2.12B0.0%	——	——	——
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)	——	$1.49B-18.2%	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$6.2B+27.9%	$579M-6.9%	$5.38B+6.2%	$5.15B+2.9%	$4.85B-6.0%
Equipment Installment Plan Receivables (Non-Current), Net	$14.34B+6.6%	$14.27B+7.8%	$13.99B+5.4%	$13.84B+8.1%	$13.45B+7.3%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	$24M-7.7%	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	——	$36M-34.5%	——	——	——
Finite Lived Intangible Assets - Gross	——	$2.61B-7.9%	——	——	——
Investments - Amortized Cost Basis	——	$3.54B-14.1%	——	——	——
Net Investment in Lease	——	$2.28B+12.6%	——	——	——
Net Operating Loss Carryforwards	——	$1.3B-3.6%	——	——	——
Intangible assets — net	——	$241M-39.6%	——	——	——
Other intangible assets—net	$419M+16.1%	$241M-39.6%	$281M-37.3%	$321M-34.2%	$361M-30.0%
Noncurrent deferred and refundable income taxes	$2.42B-27.4%	$2.88B-13.0%	$3B-1.6%	$3.43B+17.4%	$3.33B+16.6%
Long-term financing receivables (net of allowances of $27 in 2026 and $34 in 2025)	$14.34B+6.6%	$14.27B+7.8%	$13.99B+5.4%	$13.84B+8.1%	$13.45B+7.3%
Operating lease right-of-use assets	——	$708M+19.6%	——	——	——
Other non-current assets	$6.2B+27.9%	$6.1B+15.1%	$5.38B+6.2%	$5.15B+2.9%	$4.85B-6.0%
Property, plant and equipment at cost	——	$31.91B+8.2%	——	——	——
Operating Lease Income - 2026 (Lessor)	——	$104M+55.2%	——	——	——
Operating Lease Income - 2027 (Lessor)	——	$397M+25.2%	——	——	——
Operating Lease Income - 2028 (Lessor)	——	$200M+13.6%	——	——	——
Operating Lease Income - 2029 (Lessor)	——	$104M+55.2%	——	——	——
Operating Lease Income - Thereafter (Lessor)	——	$80M+116%	——	——	——
Operating Lease Right-of-Use Assets in Other Assets	——	$708M+19.6%	——	——	——
Software and Technology Licenses, Net	$6.2B+27.9%	$6.1B+15.1%	$5.38B+6.2%	$5.15B+2.9%	$4.85B-6.0%
Tax Credit Carryforward Valuation Allowance	——	$840M-3.9%	——	——	——
Accrued Manufacturing Costs	$1.43B+13.9%	$2.55B+6.8%	$2.13B+2.3%	$1.62B-3.5%	$1.26B-2.5%
Other Commercial Liabilities	$5.45B+9.3%	$5.59B+6.6%	$5.19B+4.2%	$5.21B+5.3%	$4.99B+3.5%
Commercial Paper Outstanding	——	$5.41B+37.1%	——	——	——
Accrued Liabilities, Current	$5.45B+9.3%	$5.59B+6.6%	$5.19B+4.2%	$5.21B+5.3%	$4.99B+3.5%
Compensation and benefits	$1.43B+13.9%	$2.55B+6.8%	$2.13B+2.3%	$1.62B-3.5%	$1.26B-2.5%
Other accrued liabilities	$2.57B-9.4%	$2.8B-3.8%	$2.76B-5.9%	$2.63B-8.8%	$2.83B-13.2%
Derivative Liabilities - Fair Value	——	$165M-57.1%	——	——	——
Derivative Liabilities - Not Offset Policy Election Deduction	——	$160M-14.0%	——	——	——
Derivative Liabilities Offset	——	$160M-14.0%	——	——	——
Lease Liability Payments - 2021	——	$896M+3.2%	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	$149M+24.2%	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	$98M+46.3%	——	——	——
Lease Liability Payments - Due Year Two	——	$149M+24.2%	——	——	——
Lease Liability Payments - Due Year Three	——	$115M+23.7%	——	——	——
Lease Liability Payments - Due Year Four	——	$98M+46.3%	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	$183M+16.6%	——	——	——
Operating Lease Liability Payments Due	——	$842M+24.0%	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	$114M+48.1%	——	——	——
Standard Product Warranty Accrual	——	$1.63B-4.4%	——	——	——
Supplier Finance Program Obligations	——	93,600,000,000%+10,600,000,000%	——	——	——
Carrying Amount of Hedged Term Debt	——	$6.12B+5.2%	——	——	——
Debt Instrument Face Amount	——	$1.75B+40.0%	——	——	——
Debt Maturity - 2027	——	$7.75B-0.1%	——	——	——
Debt Maturity - 5 to 10 Years	——	$383M+27.2%	——	——	——
Debt Maturity - Over 10 Years	——	$202M+98.0%	——	——	——
Defined Benefit Pension Plan Liabilities (Non-Current)	$3.66B+2.3%	$3.84B+2.2%	$3.66B-9.1%	$3.61B-9.6%	$3.58B-12.1%
Hedged Liability - Fair Value Hedge	——	-$34M+81.7%	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	$115M+23.7%	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	$74M+34.5%	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	$98M+46.3%	——	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	$74M+34.5%	——	——	——
Lease Liability Payments - Due After Year Five	——	$223M+19.3%	——	——	——
Operating Lease Liability Payments - Thereafter (Lessee)	——	$223M+19.3%	——	——	——
Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent	$3.66B+2.3%	$3.84B+2.2%	$3.66B-9.1%	$3.61B-9.6%	$3.58B-12.1%
Unrecognized Tax Benefits	——	$1.35B+4.5%	——	——	——
Unrecognized Tax Benefits - Impacting Effective Tax Rate	——	$1.2B+5.5%	——	——	——
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	——	$268M+41.1%	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	——	$26M-65.3%	——	——	——
Common Stock Shares Outstanding	——	$1.06B+70.1%	——	——	——
Cumulative Gross Losses and Impairments	——	$2.12B0.0%	——	——	——
Common stock	$5.85B-3.2%	$7.18B+3.5%	$6.22B+11.4%	$6.14B+11.3%	$6.04B+6.7%
Treasury Stock, Value	$53.31B+13.1%	$49.54B+11.7%	$48.3B+13.9%	$47.96B+15.3%	$47.13B+17.7%
ESOP Allocated Shares	——	9.6M-7.7%	——	——	——
Investments - Gross Unrealized Losses	——	$940M-56.6%	——	——	——
Number of Exercisable Options	——	2.3M-12.6%	——	——	——
Share-Based Payment Award Options Outstanding - Number	——	3M-19.2%	——	——	——
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	$209.1M+41.3%	——	——	——
Shares Reserved for Future Issuance Under Stock Plans	——	39.3M-3.8%	——	——	——
Unrealized Gains on Investments	——	$14M+119%	——	——	——
Weighted Average Exercise Price of Exercisable Options	——	$192.44+14.7%	——	——	——
Weighted Average Exercise Price of Outstanding Options	——	$220.52+12.9%	——	——	——
Aggregate Notional Principal Outstanding	——	$29.3B+8.5%	——	——	——
Nonperforming Loans and Leases Percentage	——	$25.15B+9.2%	——	——	——
Cumulative Cost Basis	——	$3.54B-14.1%	——	——	——
Deferred Revenue Timing Percentage	——	50%0.0%	——	——	——
Derivative Notional Amount	——	$29.3B+8.5%	——	——	——
Fair Value Measurement Disclosure	——	$325M-43.1%	——	——	——
Gross Assets/Liabilities	——	$325M-43.1%	——	——	——
Guarantor Obligations - Maximum Exposure	——	$458M+24.5%	——	——	——
Indemnification Liability Maximum Exposure	——	$458M+24.5%	——	——	——
Line of Credit Maximum Borrowing Capacity	——	$15.84B+8.8%	——	——	——
Line of Credit Remaining Borrowing Capacity	——	$9.66B-2.7%	——	——	——
Operating Lease Income - 2023 (Lessor)	——	$397M+25.2%	——	——	——
Operating Lease Income - 2024 (Lessor)	——	$397M+25.2%	——	——	——
Long-term accounts receivable, net	$2.49B—	$2.14B—	——	——	——
Total	——	$3.54B-14.1%	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	$378M+24.3%	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	$383M+27.2%	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	$1.49B-18.2%	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	$1.5B-16.2%	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10	——	$202M+98.0%	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10	——	$202M+98.0%	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	——	$744M-41.6%	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	$748M-41.1%	——	——	——
Available for sale investments	——	$3.55B-12.2%	——	——	——
Common Stock, Shares, Outstanding	——	$465.3M-2.6%	——	——	——
Contract with Customer, Asset, after Allowance for Credit Loss	——	$297M+24.8%	——	——	——
Contract with Customer, Liability	——	$4.68B+70.4%	——	——	——
Non-current retainage balances	——	$1.01B+57.2%	——	——	——
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	——	$26M-65.3%	——	——	——
Less than 12 months	——	$177M-79.8%	——	——	——
12 months or more	——	$763M-40.9%	——	——	——
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	——	$0-100%	——	——	——
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss	——	$26M-67.9%	——	——	——
Debt Securities, Available-for-Sale, Unrealized Loss Position	——	$940M-56.6%	——	——	——
Deferred Tax Liabilities, Gross	——	$1.8B+4.1%	——	——	——
Deferred income taxes	——	$494M+14.4%	——	——	——
Deferred Tax Assets, Gross	——	$4.9B-8.6%	——	——	——
Deferred Tax Assets, Net	——	$2.26B-18.0%	——	——	——
Deferred Tax Assets, Net of Valuation Allowance	——	$2.76B-13.6%	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits	——	$425M-24.1%	——	——	——
Deferred Tax Assets, Valuation Allowance	——	$840M-3.9%	——	——	——
Deferred Tax Liabilities, Other	——	$429M-5.5%	——	——	——
Defined Benefit Plan, Expected Gross Prescription Drug Subsidy Receipts	——	$42M-8.7%	——	——	——
Derivative, gross, assets	——	$496M+7.4%	——	——	——
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction	——	$336M+21.7%	——	——	——
Derivatives, gross, liabilities	——	$325M-43.1%	——	——	——
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction	——	$165M-57.1%	——	——	——
Potential reduction in net position of total derivative liabilities	——	$160M-14.0%	——	——	——
Notional	——	$29.3B+8.5%	——	——	——
Unrecognized compensation cost related to non-vested awards	——	$209.1M+41.3%	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	——	$2.37B-2.8%	——	——	——
2028	——	$35M-63.5%	——	——	——
2030	——	$24M-7.7%	——	——	——
2031	——	$21M-8.7%	——	——	——
2027	——	$98M-41.0%	——	——	——
2029	——	$27M-18.2%	——	——	——
Finite Lived Intangible Assets Amortization Expense After Year Five	——	$36M-34.5%	——	——	——
Gross Carrying Amount	——	$2.61B-7.9%	——	——	——
Goodwill, Gross	——	$7.44B+1.1%	——	——	——
Goodwill accumulated impairment losses	——	$2.12B0.0%	——	——	——
Value of financial guarantee (up to)	——	$458M+24.5%	——	——	——
Lessee Operating Lease Liability Payments Due	——	$842M+24.0%	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	$114M+48.1%	——	——	——
Amount outstanding under the credit facility	——	$771M+12.2%	——	——	——
Committed Revolving Credit Facilities	——	$15.84B+8.8%	——	——	——
2028	——	$8.92B+4.6%	——	——	——
2029	——	$7.75B-0.1%	——	——	——
2029	——	$1.26B-51.4%	——	——	——
2030	——	$3.11B+1,354%	——	——	——
2027	——	$7.12B+6.8%	——	——	——
Noncontrolling interests in subsidiaries	-$1M-133%	$0-100%	$1M-83.3%	$2M-66.7%	$3M-50.0%
Operating Lease Weighted Average Discount Rate Percent	——	$0.04+33.3%	——	——	——
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five	——	$17M-10.5%	——	——	——
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One	——	$6M0.0%	——	——	——
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Five	——	$4M-20.0%	——	——	——
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four	——	$5M0.0%	——	——	——
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three	——	$5M0.0%	——	——	——
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two	——	$5M-16.7%	——	——	——
Standard and Extended Product Warranty Accrual	——	$1.63B-4.4%	——	——	——
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	$30.1B+98.0%	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	——	$3.02M-19.2%	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	——	$220.52+12.9%	——	——	——
Incentive stock program, shares reserved for future grants (in shares)	——	$39.34M-3.8%	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	——	$1.06B+70.1%	——	——	——
Shares reserved for awards to employees and outside directors (in shares)	——	$42.5M0.0%	——	——	——
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable	——	$2.28M-12.6%	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	$867M+70.3%	——	——	——
Supplier finance program, obligation	——	$936M+12.8%	——	——	——
Treasury stock, shares (in shares)	——	$349.61M+3.8%	——	——	——
Unrecognized tax benefits	——	$1.35B+4.5%	——	——	——
Amount that if recognized, would affect the effective tax rate or regulatory liability	——	$1.2B+5.5%	——	——	——
Sublease Income - Thereafter	——	$80M+116%	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Caterpillar.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Caterpillar's total assets?: Caterpillar (CAT) holds $95.6B in total assets, up 12.4% year over year.
How much cash does Caterpillar have?: Caterpillar holds $4.1B in cash and equivalents.
Can Caterpillar cover its short-term obligations?: Its current ratio is 1.35 — current assets exceed current liabilities.
Where does Caterpillar's balance sheet data come from?: Every line is extracted from Caterpillar's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.